The correlation of vitamin D with HOMA-IR and glycated hemoglobin in type 2 diabetes mellitus patients

Authors

  • Sujesh-Kumar Narayanan Department of Biochemistry, Sree Uthradom Thirunal (SUT) Academy of Medical Sciences, Trivandrum, Kerala, India
  • Renjith Gopikuttan Department of Biochemistry, Sree Uthradom Thirunal (SUT) Academy of Medical Sciences, Trivandrum, Kerala, India

DOI:

https://doi.org/10.47419/bjbabs.v3i04.153

Keywords:

HOMA-IR, HbA1c, type 2 diabetes mellitus, vitamin D

Abstract

Background and objective: Vitamin D’s primary functions are the homeostasis of calcium and bone metabolism, but it also has a significant role in the homeostasis of plasma glucose. This study sought to examine the relationship between vitamin D and glycated hemoglobin and insulin resistance in type 2 diabetes mellitus (T2DM).

Methods: A total of 150 patients with newly diagnosed T2DM participated in this case-control study. Additionally, 150 controls of the same age and gender were also recruited. Serum vitamin D and fasting insulin levels were estimated by the electrochemiluminescence immunoassay (ECLIA) method. And, high-performance liquid chromatography (HPLC) was used to analyze HbA1c. Pearson’s correlation coefficient was used to determine the association of vitamin D with HbA1c and HOMA-IR.

Results: About 71% of diabetes patients had low vitamin D levels, compared to 31% in the control group. Vitamin D-deficient T2DM subjects had significantly higher HOMA-IR and HbA1c levels. In addition, a strong negative association between vitamin D and HOMA-IR (r = -0.75) and vitamin D and HbA1c (r = -0.73) has been demonstrated among T2DM patients.

Conclusions: Vitamin D deficiency is correlated with ineffective glycemic control, and the reason might be its potential role in the secretion and sensitivity of insulin. Therefore, vitamin D screening must be incorporated as a routine check-up for T2DM patients.

Metrics

Metrics Loading ...

Downloads

Download data is not yet available.

References

American Diabetes Association “Diagnosis and classification of diabetes mellitus”. Diabetes Care 31(Suppl 1) (2011), S62–S69. DOI: 10.2337/dc10-S062.

A Aregbesola et al. “Gender difference in type 2 diabetes and the role of body iron stores”. Ann Clin Biochem 54(1) (2017), pp. 113–120. DOI: 10.1177/0004563216646397.

A G Pittas et al. “The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis”. J Clin Endocrinol Metab 92(6) (2007), pp. 2017–2029. DOI: 10.1210/jc.2007-0298.

A M Borissova et al. “The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients”. Int J Clin Pract 57(4) (2003), pp. 258–261. DOI: 12800453.

A W Norman et al. “Vitamin D deficiency inhibits pancreatic secretion of insulin”. Science 209(4458) (1980), pp. 823–825. DOI: 10.1126/science.6250216.

B Maestro et al. “Stimulation by 1,25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells”. Endocr J 47(4) (2000), pp. 383–391. DOI: 10.1507/endocrj.47.383.

B Singh and A Saxena. “Surrogate markers of insulin resistance: A review”. World J Diabetes 1(2) (2010), pp. 36–47. DOI: 10.4239/wjd.v1.i2.36.

B Thorand et al. “Effect of serum 25-hydroxyvitamin D on risk for type 2 diabetes may be partially mediated by subclinical inflammation: results from the MONICA/KORA Augsburg study”. Diabetes Care 34(10) (2011), pp. 2320–2322. DOI: 10.2337/dc11-0775.

C A Peterson, A K Tosh, and A M Belenchia. “Vitamin D insufficiency and insulin resistance in obese adolescents”. Ther Adv Endocrinol Metab 5(6) (2014), pp. 166–189. DOI: 10.1177/2042018814547205.

D D Bikle. “Vitamin D metabolism, mechanism of action, and clinical applications”. Chem Biol 21(3) (2014), pp. 319–329. DOI: 10.1016/j.chembiol.2013.12.016.

D R Matthews et al. “Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man”. Diabetologia 28(7) (1985), pp. 412–419. DOI: 10.1007/BF00280883.

E Bonora et al. “Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity”. Diabetes Care 23(1) (2000), pp. 57–63. DOI: 10.2337/diacare.23.1.57.

G S Hotamisligil et al. “Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance”. J Clin Invest 95(5) (1995), pp. 2409–2415. DOI: 10.1172/JCI117936.

I Kostoglou-Athanassiou et al. “Vitamin D and glycemic control in diabetes mellitus type 2”. Ther Adv Endocrinol Metab 4(4) (2013), pp. 122–128. DOI: 10.1177/2042018813501189.

J A Alvarez and A Ashraf. “Role of vitamin d in insulin secretion and insulin sensitivity for glucose homeostasis”. Int J Endocrinol (2010), pp. 351385–351385. DOI: 10.1155/2010/351385.

K C Chiu et al. “Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction”. Am J Clin Nutr 79(5) (2004), pp. 820–825. DOI: 10.1093/ajcn/79.5.820.

M A Bayani et al. “Status of vitamin-D in diabetic patients”. Caspian J Intern Med 5(1) (2014), pp. 40–42.

M Blum et al. “Vitamin D(3) in fat tissue”. Endocrine 33(1) (2008), pp. 90–94. DOI: 10.1007/s12020-008-9051-4.

M F Holick. “Vitamin D status: measurement, interpretation, and clinical application”. Ann Epidemiol 19(2) (2009), pp. 73–78. DOI: 10.1016/j.annepidem.2007.12.001.

M S Hutchinson et al. “Serum 25-hydroxyvitamin D levels are inversely associated with glycated haemoglobin (HbA1c). The Tromso Study”. Scand J Clin Lab Invest 71(5) (2011), pp. 399–406. DOI: 10.3109/00365513.2011.575235.

P Lemieux et al. “Effects of 6-month vitamin D supplementation on insulin sensitivity and secretion: a randomised, placebo-controlled trial”. Eur J Endocrinol 181(3) (2019), pp. 287–299. DOI: 10.1530/EJE-19-0156.

S Ghavam et al. “Evaluation of HbA1C and serum levels of vitamin D in diabetic patients”. J Family Med Prim Care 7(6) (2018), pp. 1314–1318. DOI: 10.4103/jfmpc.jfmpc_73_18.

S I Sherwani et al. “Significance of HbA1c test in diagnosis and prognosis of diabetic patients”. Biomark Insights 11 (2016), pp. 95–104. DOI: 10.4137/BMI.S38440.

S Kumar et al. “Improvement in glucose tolerance and beta-cell function in a patient with vitamin D deficiency during treatment with vitamin D”. Postgrad Med J 70(824) (1994), pp. 440–443. DOI: 10.1136/pgmj.70.824.440.

X Palomer et al. “Role of vitamin D in the pathogenesis of type 2 diabetes mellitus”. Diabetes Obes Metab 10(3) (2008), pp. 185–197. DOI: 10.1111/j.1463-1326.2007.00710.x.

Y Gao et al. “The relationship between serum 25-hydroxy vitamin D and insulin sensitivity and β-cell function in newly diagnosed type 2 diabetes”. J Diabetes Res (2015), pp. 636891–636891. DOI: 10.1155/2015/636891.

Y Singh et al. “A study of insulin resistance by HOMA-IR and its cut-off value to identify metabolic syndrome in urban Indian adolescents”. J Clin Res Pediatr Endocrinol 5(4) (2013), pp. 245–251. DOI: 10.4274/Jcrpe.1127.

Yousefi Rad et al. “The effects of vitamin D supplementation on glucose control and insulin resistance in patients with diabetes type 2: A randomized clinical trial study”. Iran J Public Health 43(12) (2014), pp. 1651–1656.

GA-153-2022

Published

08-11-2022

How to Cite

The correlation of vitamin D with HOMA-IR and glycated hemoglobin in type 2 diabetes mellitus patients. (2022). Baghdad Journal of Biochemistry and Applied Biological Sciences, 3(04), 273-285. https://doi.org/10.47419/bjbabs.v3i04.153

Metrics

Share